Literature DB >> 6703480

Familial primary pulmonary hypertension: clinical patterns.

J E Loyd, R K Primm, J H Newman.   

Abstract

We recently identified a family with 6 deaths in 2 generations from primary pulmonary hypertension. The disease was undiagnosed in several of them, and the family members, geographically separated, were unaware that there was a familial disease. We hypothesized that familial primary pulmonary hypertension (FPPH) might be labeled as nonfamilial in situations where the family history was incomplete. In order to better define the clinical patterns of transmission of known FPPH, we surveyed as many of the previously reported families as possible (9 of 13) and found 8 new cases in 5 of these families. Looking at all cases, the most important finding was the infrequent expression of the gene within some families and the widely differing frequency of expression among families. The pattern was autosomal dominant with a 2:1 female-to-male ratio. One instance of male-to-male transmission excluded x-linkage of the gene. Survival after onset of symptoms was the same as that reported for nonfamilial primary pulmonary hypertension (PPH). We conclude that many apparently nonfamilial cases of PPH may actually have the same etiology as in FPPH.

Entities:  

Mesh:

Year:  1984        PMID: 6703480     DOI: 10.1164/arrd.1984.129.1.194

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  43 in total

Review 1.  Primary pulmonary hypertension.

Authors:  A J Peacock
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

Review 2.  Primary pulmonary hypertension: the pressure rises for a gene.

Authors:  J R Thomson; R C Trembath
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

Review 3.  Primary pulmonary hypertension in childhood.

Authors:  S G Haworth
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 4.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  Recommendations on the management of pulmonary hypertension in clinical practice.

Authors: 
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 6.  Epidemiology of pulmonary arterial hypertension.

Authors:  Xin Jiang; Zhi-Cheng Jing
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 7.  When to offer genetic testing for pulmonary arterial hypertension.

Authors:  Wendy K Chung; Eric D Austin; D Hunter Best; Lynette M Brown; C Gregory Elliott
Journal:  Can J Cardiol       Date:  2014-11-11       Impact factor: 5.223

8.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.

Authors:  R E Harrison; J A Flanagan; M Sankelo; S A Abdalla; J Rowell; R D Machado; C G Elliott; I M Robbins; H Olschewski; V McLaughlin; E Gruenig; F Kermeen; M Halme; A Räisänen-Sokolowski; T Laitinen; N W Morrell; R C Trembath
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

9.  Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension.

Authors:  J E Loyd; M G Butler; T M Foroud; P M Conneally; J A Phillips; J H Newman
Journal:  Am J Respir Crit Care Med       Date:  1995-07       Impact factor: 21.405

10.  Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension.

Authors:  Eric D Austin; John A Phillips; Joy D Cogan; Rizwan Hamid; Chang Yu; Krista C Stanton; Charles A Phillips; Lisa A Wheeler; Ivan M Robbins; John H Newman; James E Loyd
Journal:  Respir Res       Date:  2009-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.